About Insilico Medicine
Insilico Medicine is an end-to-end, clinical-stage AI-driven drug discovery company that uses generative AI and reinforcement learning to design novel drug candidates.
Mission & Story
Mission
Our mission is to extend healthy productive longevity for everyone by transforming drug discovery and development with generative artificial intelligence, significantly reducing the time and cost to bring life-saving medications to patients.
Founding Story
Founded in 2014 by Alex Zhavoronkov, PhD, who has a combined background in biomedicine and computer technology. Dr. Zhavoronkov pioneered the application of Generative Adversarial Networks (GANs) and Reinforcement Learning (RL) to drug discovery in 2016, discovering novel targets and generating novel molecules with desired properties.
Clinical Focus
Medical conditions and clinical areas addressed by Insilico Medicine.
Who It Serves
Milestones & Awards
Recent Milestones
Named most innovative biotechnology company in the world 2024. Multiple drug candidates advancing to clinical stages. Established global presence across U.S., Greater China, Canada, and Middle East.
Awards & Recognition
Most innovative biotechnology company in the world 2024. Founder recognized as Top 100 AI Leaders in Drug Discovery by Deep Knowledge Analytics (2019). Founder selected as Clarivate Global Highly Cited Scientist (2022). President Alex Aliper selected as top 20 under 40 biotechnology executives globally by Endpoint News (2020).
Key Partnerships
Social & Media
Follow on
Latest Updates
New Milestone in AI Drug Discovery: First Generative AI Drug Begins Phase II Trials with Patients
Case Study: Insilico's Transformation
Insilico Medicine is Using Generative AI to Design New Drugs for Rare Diseases
Teaching AI the Language of Molecules: How MMAI Gym and Liquid Intelligence are Solving the “Brute Force” Crisis in Drug Discovery
Science42: DORA.Introducing the Draft Outline Research Assistant workflow
Insilico Medicine in the News
All News →
Company Details
- Founded
- 2014
- Headquarters
- Hong Kong, China
- Employees
- 285
- Stage
- growth
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 40 →
1upHealth
AI-powered health data platform that integrates and normalizes patient data from multiple sources to enable interoperability and clinical decision support across healthcare systems.
Aidbox
Health Samurai provides Aidbox, an enterprise FHIR server and backend platform that enables healthcare organizations to build solutions from clinical data repositories to EHRs. The platform offers PostgreSQL-based FHIR data management, multi-version FHIR support (STU3, R4, R5, R6), and comprehensive SDKs for rapid development.
Altera Digital Health
Altera Digital Health provides comprehensive EHR and healthcare IT solutions for hospitals, health systems, and physician practices. The company offers acute, ambulatory, and financial platforms including Sunrise, Paragon, TouchWorks EHR, and CareInMotion interoperability solutions, alongside AI-powered tools for clinical documentation and revenue cycle management.
Amigo AI
Amigo AI provides an enterprise platform for healthcare organizations to build, train, and deploy clinical AI agents that handle patient interactions across multiple specialties. The platform uses a rigorous 'Digital Residency' training approach with simulated patient scenarios to ensure clinical safety before deployment.
athenahealth
1001-5000 employees
athenahealth provides cloud-based healthcare technology solutions including EHR, revenue cycle management, and patient engagement tools. The company serves healthcare organizations of all sizes with an integrated platform designed to improve clinical and financial outcomes.
Atropos Health
Atropos Health generates high-quality, personalized Real-World Evidence (RWE) in minutes using AI-powered automation. The company serves health systems, life sciences, and researchers with publication-grade observational studies to support clinical decisions, formulary management, and regulatory research.
Autonomize
Autonomize AI provides an AI-native intelligence platform that transforms fragmented healthcare operations into autonomous, intelligent workflows. The company deploys healthcare-specific AI agents and workflows across utilization management, care management, claims, pharmacy, and appeals for health systems and payers.
AvoMD
AvoMD provides EHR-integrated AI copilots that combine patient data with trusted medical guidelines to support clinical workflows. Their platform includes ambient documentation, chart assistance, AI consult tools, and intelligent pathways for hospitals and ambulatory care settings.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.